Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d190ff62e7e6bdccf09ebe38a6d85c2f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2017-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60599cb14281da5569e3432cbff9fd6e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac25d9bf85dd2d9e9d00f330261713dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4faf0b57f08d34b36afb46b75a102d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7df1227ed6e0635f3193b9791652432f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_397229b721e598ebdffdeef8235542cb |
publicationDate |
2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10688180-B2 |
titleOfInvention |
Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer |
abstract |
Provided are methods for clinical treatment of cancer (e.g., solid tumors or hematological malignancies) using an anti-KIR antibody in combination with an anti-CTLA-4 antibody. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11365393-B2 |
priorityDate |
2012-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |